Clinical Research Directory
Browse clinical research sites, groups, and studies.
Metagenomic Next-Generation Sequencing for the Diagnosis of Fracture-related Infection
Sponsor: Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Summary
The value of next-generation sequencing (NGS) using Nanopore technology has been demonstrated in the case of diabetic patients' wounds or in prosthetic joint infections. The aim of this study is to demonstrate its relevance as a new diagnostic approach for fracture-related infections (FRI). Bone samples from patient with FRI will be submitted to shotgun metagenomic Next-generation sequencing using Oxford Nanopore Technology (ONT) in order to establish its diagnostic value in this context in comparison with the reference method.
Official title: Contribution of Metagenomic Sequencing Using Nanopore Technology to the Management of Post-traumatic Bone and Joint Infections
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
100
Start Date
2024-03-11
Completion Date
2025-12-31
Last Updated
2025-12-05
Healthy Volunteers
No
Interventions
Metagenomic sequencing
Samples shall be submitted to high throughput sequencing using both illumine MiSeq and Oxford Nanopore Technologies.
Locations (2)
IHU, service des maladies infectieuses chroniques
Marseille, Bouches-du-Rhône, France
Military Teaching Hospital Sainte Anne
Toulon, VAR, France